Donald R. A. Uges

5.8k total citations
143 papers, 4.2k citations indexed

About

Donald R. A. Uges is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Donald R. A. Uges has authored 143 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pharmacology, 32 papers in Oncology and 29 papers in Molecular Biology. Recurrent topics in Donald R. A. Uges's work include Antibiotics Pharmacokinetics and Efficacy (29 papers), Poisoning and overdose treatments (14 papers) and Cancer therapeutics and mechanisms (13 papers). Donald R. A. Uges is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (29 papers), Poisoning and overdose treatments (14 papers) and Cancer therapeutics and mechanisms (13 papers). Donald R. A. Uges collaborates with scholars based in Netherlands, United States and New Zealand. Donald R. A. Uges's co-authors include Jan‐Willem C. Alffenaar, Ben Greijdanus, Remco A. Koster, Elisabeth G.E. de Vries, Jos G. W. Kosterink, Tjip S. van der Werf, Jan Piet Franke, Siebold S.N. de Graaf, Toine C. G. Egberts and Harry J.M. Groen and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Donald R. A. Uges

138 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald R. A. Uges Netherlands 39 979 944 857 712 542 143 4.2k
Fritz Sörgel Germany 40 1.8k 1.8× 1.0k 1.1× 691 0.8× 723 1.0× 1.3k 2.3× 144 5.4k
Saı̈k Urien France 43 692 0.7× 1.4k 1.5× 1.3k 1.6× 995 1.4× 639 1.2× 283 6.2k
Antona J. Wagstaff New Zealand 41 751 0.8× 854 0.9× 631 0.7× 316 0.4× 916 1.7× 145 5.9k
Mary H. H. Ensom Canada 39 866 0.9× 572 0.6× 466 0.5× 751 1.1× 718 1.3× 194 5.4k
Robert Farinotti France 45 1.4k 1.4× 1.1k 1.1× 1.6k 1.8× 1.1k 1.6× 839 1.5× 291 7.3k
Kishor M. Wasan Canada 45 527 0.5× 2.1k 2.2× 952 1.1× 885 1.2× 741 1.4× 238 7.6k
Katharina Rentsch Switzerland 46 546 0.6× 1.4k 1.5× 699 0.8× 516 0.7× 535 1.0× 186 6.3k
Markus Müller Austria 44 1.7k 1.8× 637 0.7× 1.4k 1.7× 450 0.6× 714 1.3× 130 5.2k
Stephen P. Clissold France 35 1.1k 1.1× 966 1.0× 472 0.6× 813 1.1× 1.2k 2.1× 53 6.2k
Joo‐Youn Cho South Korea 40 494 0.5× 1.6k 1.7× 1.3k 1.5× 535 0.8× 592 1.1× 289 5.8k

Countries citing papers authored by Donald R. A. Uges

Since Specialization
Citations

This map shows the geographic impact of Donald R. A. Uges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald R. A. Uges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald R. A. Uges more than expected).

Fields of papers citing papers by Donald R. A. Uges

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald R. A. Uges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald R. A. Uges. The network helps show where Donald R. A. Uges may publish in the future.

Co-authorship network of co-authors of Donald R. A. Uges

This figure shows the co-authorship network connecting the top 25 collaborators of Donald R. A. Uges. A scholar is included among the top collaborators of Donald R. A. Uges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald R. A. Uges. Donald R. A. Uges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bolhuis, Mathieu S., Richard van Altena, Dick van Soolingen, et al.. (2013). Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients. European Respiratory Journal. 42(6). 1614–1621. 46 indexed citations
2.
Nielsen, Xiaohui Chen, Kim Dalhoff, Jan‐Willem C. Alffenaar, et al.. (2013). Pharmacokinetic variability of clarithromycin and differences in CYP3A4 activity in patients with cystic fibrosis. Journal of Cystic Fibrosis. 13(2). 179–185. 10 indexed citations
3.
Alffenaar, Jan‐Willem C., et al.. (2011). Determination of ribavirin in human serum using liquid chromatography tandem mass spectrometry. Talanta. 88. 385–390. 14 indexed citations
4.
Alffenaar, Jan‐Willem C., Richard van Altena, A. Mireille A. Wessels, et al.. (2010). Comparison of the Pharmacokinetics of Two Dosage Regimens of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Patients. Clinical Pharmacokinetics. 49(8). 559–565. 39 indexed citations
5.
Smink, B. E., Klaas J. Lusthof, J.J. de Gier, Donald R. A. Uges, & Toine C. G. Egberts. (2008). The relation between the blood benzodiazepine concentration and performance in suspected impaired drivers. Journal of Forensic and Legal Medicine. 15(8). 483–488. 16 indexed citations
6.
Alffenaar, Jan‐Willem C., Willemien A. Nienhuis, Femke de Velde, et al.. (2008). Pharmacokinetics of Rifampicin and Clarithromycin in Patients Treated for Mycobacterium ulcerans Infection in Ghana. 46th Annual Meeting. 1 indexed citations
7.
Wilffert, Bob, et al.. (2007). 4-Aminopyridine (fampridine) effectively treats amlodipine poisoning: a case report. Journal of Clinical Pharmacy and Therapeutics. 32(6). 655–657. 3 indexed citations
8.
Neef, Cees, et al.. (2006). Pitfalls in TDM of Antibiotic Drugs: Analytical and Modelling Issues. Therapeutic Drug Monitoring. 28(5). 686–689. 13 indexed citations
9.
Hendriks, G., Jan Piet Franke, & Donald R. A. Uges. (2005). New practical algorithm for modelling retention times in gradient reversed-phase high-performance liquid chromatography. Journal of Chromatography A. 1089(1-2). 193–202. 12 indexed citations
10.
Bond, G. Randall, Paul E. Steele, & Donald R. A. Uges. (2003). Massive Venlafaxine Overdose Resulted in a False Positive Abbott AxSYM®Urine Immunoassay for Phencyclidine. Journal of Toxicology Clinical Toxicology. 41(7). 999–1002. 27 indexed citations
11.
Maring, Jan Gerard, André B. P. Kuilenburg, Janet Haasjes, et al.. (2002). Reduced 5-FU clearance in a patient with low DPD activity due to heterozygosity for a mutant allele of the DPYD gene. British Journal of Cancer. 86(7). 1028–1033. 78 indexed citations
12.
Ginkel, Robert J. van, Heimen Schraffordt Koops, Elisabeth G.E. de Vries, et al.. (1996). Hyperthermic isolated limb perfusion with cisplatin in four patients with sarcomas of soft tissue and bone. European Journal of Surgical Oncology. 22(5). 528–531. 18 indexed citations
13.
Guchelaar, Henk‐Jan, Elisabeth G.E. de Vries, Coby Meijer, et al.. (1994). Effect of Ultrafilterable Platinum Concentration on Cisplatin and Carboplatin Cytotoxicity in Human Tumor and Bone Marrow Cells in Vitro. Pharmaceutical Research. 11(9). 1265–1269. 3 indexed citations
14.
Gietema, Jourik A., Elisabeth G.E. de Vries, Dirk Th. Sleijfer, et al.. (1993). A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 days. British Journal of Cancer. 67(2). 396–401. 45 indexed citations
15.
Uges, Donald R. A., et al.. (1992). Clinical and pharmaceutical aspects in acute poisoning. Pharmacy World & Science. 14(3). 78–82. 1 indexed citations
16.
Timmer‐Bosscha, Hetty, Geke A.P. Hospers, Coby Meijer, et al.. (1989). Influence of Docosahexaenoic Acid on Cisplatin Resistance in a Human Small Cell Lung Carcinoma Cell Line. JNCI Journal of the National Cancer Institute. 81(14). 1069–1075. 56 indexed citations
17.
Uges, Donald R. A.. (1987). Establishment and Interpretation of Reference Values for Therapeutic Drug-Monitoring, Clinical and Forensic Toxicology. University of Groningen research database (University of Groningen / Centre for Information Technology). 29. 84–86. 1 indexed citations
18.
Uges, Donald R. A., et al.. (1984). THE DETERMINATION OF ATRACURIUM AND ITS MAIN METABOLITE LAUDANOSINE IN SERUM BY HPLC. Pharmacy World & Science. 6(6). 265–265. 3 indexed citations
19.
Uges, Donald R. A., et al.. (1984). [Rohypnol poisoning as a cause of postanesthetic coma and the success of 4-aminopyridine therapy].. PubMed. 33(6). 294–5. 1 indexed citations
20.
Uges, Donald R. A.. (1982). 4-AMINOPYRIDINE, CLINICAL PHARMACEUTICAL, PHARMACOLOGICAL AND TOXICOLOGICAL ASPECTS. Data Archiving and Networked Services (DANS). 5(5). 256–257. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fritz Sörgel Breakdown of academic impact, for papers by Saı̈k Urien Breakdown of academic impact, for papers by Antona J. Wagstaff Breakdown of academic impact, for papers by Mary H. H. Ensom Breakdown of academic impact, for papers by Robert Farinotti Breakdown of academic impact, for papers by Kishor M. Wasan Breakdown of academic impact, for papers by Katharina Rentsch Breakdown of academic impact, for papers by Markus Müller Breakdown of academic impact, for papers by Stephen P. Clissold Breakdown of academic impact, for papers by Joo‐Youn Cho
Rankless by CCL
2026